Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Form 8.3

19 Feb 2026 13:29

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

SAMSON ROCK CAPITAL LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

IDOX PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

18/02/2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

1p ORDINARY

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

19,165,612

4.15

(2) Cash-settled derivatives:

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

19,165,612

4.15

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

1p ORDINARY

Purchase

183,828

70.597338 GBp

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

19/02/2026

Contact name:

Des Denning

Telephone number*:

02039941800

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260219460176/en/

Copyright Business Wire 2026

Date   Source Headline
24th Apr 20184:32 pmRNSHolding(s) in Company
24th Apr 201810:24 amRNSHolding(s) in Company
23rd Apr 20183:40 pmRNSHolding(s) in Company
19th Apr 20183:58 pmRNSResult of AGM and Board Change
19th Apr 20183:54 pmRNSAGM Statement and Trading Update
19th Apr 20187:00 amRNSAGM Statement and Trading Update
27th Mar 20185:17 pmRNSDirector/PDMR Shareholding
27th Mar 201811:02 amRNSPosting of Annual Report and Notice of AGM
22nd Mar 20185:27 pmRNSHolding(s) in Company
19th Mar 201811:22 amRNSHolding(s) in Company
15th Mar 20185:17 pmRNSVesting of LTIP
8th Mar 20184:43 pmRNSHolding(s) in Company
1st Mar 201812:25 pmRNSDirectorate Change
1st Mar 201811:30 amRNSHolding(s) in Company
1st Mar 20187:00 amRNSFinal Results
20th Feb 201812:24 pmRNSHolding(s) in Company
2nd Feb 20184:12 pmRNSHolding(s) in Company
2nd Feb 20188:58 amRNSHolding(s) in Company
31st Jan 20184:52 pmRNSHolding(s) in Company
25th Jan 201812:34 pmRNSDirector/PDMR Shareholding
5th Jan 20184:40 pmRNSSecond Price Monitoring Extn
5th Jan 20184:35 pmRNSPrice Monitoring Extension
3rd Jan 201810:51 amRNSHolding(s) in Company
27th Dec 20171:48 pmRNSHolding(s) in Company
13th Dec 20177:00 amRNSYear End Update and Board Change
14th Nov 20173:45 pmRNSYear End Trading Update
2nd Nov 20171:31 pmRNSDirector Update
22nd Sep 20172:33 pmRNSExercise of Options and Total Voting Rights
20th Sep 20179:32 amRNSHolding(s) in Company
4th Sep 201710:38 amRNSDirectors' Dealing, Exercise of Options & TVR
1st Sep 20176:16 pmRNSHolding(s) in Company
23rd Aug 20176:06 pmRNSHolding(s) in Company
17th Aug 20177:00 amRNSAcquisition
4th Aug 20174:20 pmRNSDirector and PCA Dealing
14th Jul 20173:52 pmRNSDirector/PDMR Shareholding
6th Jul 20174:35 pmRNSPrice Monitoring Extension
29th Jun 20175:23 pmRNSDirector/PDMR Shareholding and Total Voting Rights
6th Jun 20177:00 amRNSHalf-year Report
18th May 20177:00 amRNSHalf Year Trading Update and Notice of Results
17th May 20174:31 pmRNSHolding(s) in Company
18th Apr 20173:45 pmRNSDirector/PDMR Shareholding and Total Voting Rights
7th Apr 20172:27 pmRNSDirector/PDMR Shareholding
22nd Mar 20179:22 amRNSDirector and PCA Dealing
24th Feb 201712:53 pmRNSResult of AGM
24th Feb 20177:00 amRNSAGM Trading Update
15th Feb 20172:55 pmRNSHolding(s) in Company
14th Feb 20171:24 pmRNSExercise of Options and Total Voting Rights
10th Feb 20173:39 pmRNSDirector/PDMR Shareholding
6th Feb 20176:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20179:48 amRNSDirectors' Dealing, Exercise of Options and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.